Clarus Therapeutics Hldgs Inc (CRXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRXT | ZTS | TAK | NBIX | UTHR |
| Company | Clarus Therapeutics Hldgs Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Neurocrine Bioscienc | United Therapeutic |
| Price Information | |||||
| Exchange | OTC US | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 0.0650 | 175.20 | 13.12 | 138.25 | 312.65 |
| High | 0.0749 | 175.96 | 13.23 | 139.72 | 314.85 |
| Low | 0.0475 | 174.25 | 13.11 | 135.85 | 311.45 |
| Last | 0.0475 | 174.96 | 13.21 | 139.08 | 314.56 |
| Change | -0.0215 | -0.64 | +0.10 | +0.85 | +3.52 |
| % Change | -31.16% | -0.36% | +0.76% | +0.61% | +1.13% |
| Volume | 2,737,100 | 1,812,000 | 981,100 | 445,200 | 460,500 |
| 20-Day Average Volume | 4,348,840 | 2,469,255 | 1,558,160 | 797,440 | 653,510 |
| Previous Close | 0.0690 | 175.60 | 13.11 | 138.23 | 311.04 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2088 | 173.36 | 13.07 | 135.42 | 302.11 |
| 20-Day Raw Stochastic | 0.00% | 55.95% | 64.80% | 79.04% | 81.16% |
| 20-Day Relative Strength | 26.48% | 54.52% | 51.48% | 53.62% | 71.52% |
| Weighted Alpha | -96.72 | +2.30 | -14.56 | +40.57 | +57.98 |
| Today's Opinion | 100% Sell | 8% Sell | 72% Sell | 64% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 8% Sell | 88% Sell | 64% Buy | 100% Buy |
| Last Month's Opinion | 100% Sell | 40% Sell | 72% Sell | 40% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -69.75% since 08/29/22 | -0.85% since 06/27/24 | +2.32% since 06/27/24 | +3.55% since 06/27/24 | -0.75% since 06/27/24 |
| Low | 0.0475 on 09/06/22 | 172.00 on 07/01/24 | 12.94 on 06/28/24 | 134.96 on 06/28/24 | 309.04 on 07/03/24 |
| High | 0.1400 on 08/30/22 | 177.67 on 07/03/24 | 13.23 on 07/05/24 | 141.66 on 07/01/24 | 325.00 on 07/01/24 |
| 1-Month | |||||
| %Chg | -84.34% since 08/05/22 | -0.49% since 06/05/24 | -2.22% since 06/05/24 | +4.03% since 06/05/24 | +13.67% since 06/05/24 |
| Low | 0.0475 on 09/06/22 | 166.45 on 06/26/24 | 12.57 on 06/20/24 | 129.33 on 06/20/24 | 269.59 on 06/10/24 |
| High | 0.3489 on 08/15/22 | 181.66 on 06/27/24 | 13.56 on 06/10/24 | 141.66 on 07/01/24 | 325.00 on 07/01/24 |
| 3-Month | |||||
| %Chg | -90.08% since 06/06/22 | +5.49% since 04/05/24 | -3.01% since 04/05/24 | +0.12% since 04/05/24 | +34.68% since 04/05/24 |
| Low | 0.0475 on 09/06/22 | 144.80 on 04/22/24 | 12.57 on 06/20/24 | 129.33 on 06/20/24 | 230.39 on 04/16/24 |
| High | 0.4659 on 06/07/22 | 181.66 on 06/27/24 | 13.77 on 04/08/24 | 145.78 on 05/22/24 | 325.00 on 07/01/24 |
| 6-Month | |||||
| %Chg | -93.21% since 03/04/22 | -10.21% since 01/05/24 | -10.26% since 01/05/24 | +4.98% since 01/05/24 | +37.12% since 01/05/24 |
| Low | 0.0475 on 09/06/22 | 144.80 on 04/22/24 | 12.57 on 06/20/24 | 128.00 on 02/07/24 | 208.62 on 02/08/24 |
| High | 3.9400 on 04/20/22 | 200.53 on 02/29/24 | 15.07 on 01/12/24 | 148.37 on 03/21/24 | 325.00 on 07/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,471 | 79,833,376 | 41,807,496 | 13,996,594 | 13,952,620 |
| Shares Outstanding, K | 52,021 | 456,295 | 3,164,837 | 100,637 | 44,356 |
| Annual Sales | 13,960,000 | 8,544,000,000 | 29,419,960,000 | 1,887,100,000 | 2,327,500,000 |
| Annual Net Income | -40,620,000 | 2,344,000,000 | 994,060,000 | 249,700,000 | 984,800,000 |
| Last Quarter Sales | 4,050,000 | 2,190,000,000 | 6,938,670,000 | 515,300,000 | 677,700,000 |
| Last Quarter Net Income | -10,690,000 | 599,000,000 | -46,010,000 | 43,400,000 | 306,600,000 |
| 60-Month Beta | 1.96 | 0.86 | 0.54 | 0.37 | 0.55 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.24 on 08/18/22 | 1.38 on 05/02/24 | 0.00 on 05/09/24 | 0.42 on 05/01/24 | 6.17 on 05/01/24 |
| Latest Earnings Date | 08/22/22 | 08/06/24 | 07/25/24 | 08/06/24 | 08/07/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 07/18/24 | 03/27/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 32.58 | 8.40 | 38.08 | 14.71 |